BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24222159)

  • 1. Concurrent chemoradiotherapy for non-bulky stage IB/II cervical cancer without pelvic node enlargement.
    Wakayama A; Inamine M; Kudaka W; Nagai Y; Nakamoto T; Ooyama T; Ariga T; Kasuya G; Toita T; Aoki Y
    Anticancer Res; 2013 Nov; 33(11):5123-6. PubMed ID: 24222159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
    Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk group for locoregional recurrence in patients with stage IB-IIB squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.
    Hirakawa M; Nagai Y; Toita T; Kudaka W; Inamine M; Ogawa K; Murayama S; Aoki Y
    Anticancer Res; 2011 Apr; 31(4):1437-41. PubMed ID: 21508399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
    Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
    Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
    Lim A; Sia S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1431-8. PubMed ID: 21640504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
    Kim YB; Cho JH; Keum KC; Lee CG; Seong J; Suh CO; Kim GE
    Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma.
    Mabuchi S; Okazawa M; Matsuo K; Kawano M; Suzuki O; Miyatake T; Enomoto T; Kamiura S; Ogawa K; Kimura T
    Gynecol Oncol; 2012 Oct; 127(1):114-20. PubMed ID: 22728518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
    Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of completion surgery after concurrent radiochemotherapy in locally advanced stages IB2-IIB cervical cancer.
    Chereau E; DE LA Hosseraye C; Ballester M; Monnier L; Rouzier R; Touboul E; Daraï E
    Anticancer Res; 2013 Apr; 33(4):1661-6. PubMed ID: 23564812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
    Werner-Wasik M; Schmid CH; Bornstein L; Ball HG; Smith DM; Madoc-Jones H
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1309-17. PubMed ID: 7635770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of epidermal growth factor receptor expression on disease-free survival and rate of pelvic relapse in patients with advanced cancer of the cervix treated with chemoradiotherapy.
    Pérez-Regadera J; Sánchez-Muñoz A; De-la-Cruz J; Ballestín C; Lora D; García-Martín R; Sotoca A; Pérez-Ruiz E; Lanzós E
    Am J Clin Oncol; 2011 Aug; 34(4):395-400. PubMed ID: 20859196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
    Stock RG; Chen AS; Karasek K
    Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
    Tang Q; Tu YQ; Chen JH; Lyu XJ; Yan DD
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):462-466. PubMed ID: 29936774
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy.
    Hu K; Wang W; Liu X; Meng Q; Zhang F
    Radiat Oncol; 2018 Dec; 13(1):249. PubMed ID: 30558636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolated pelvic recurrences of cervical carcinoma treated with salvage chemoradiotherapy].
    Besson N; Touboul E; Daraï É; Lefranc JP; Monnier L; Schlienger M; Huguet F
    Cancer Radiother; 2014 Mar; 18(2):83-8. PubMed ID: 24462252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.
    Hirakawa M; Nagai Y; Inamine M; Kamiyama K; Ogawa K; Toita T; Murayama S; Aoki Y
    Gynecol Oncol; 2008 Jan; 108(1):126-9. PubMed ID: 17936344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer.
    Kobayashi Y; Ohara T; Wada Y; Okuda Y; Kondo H; Okuma Y; Suzuki N; Gomi H; Kiguchi K; Ishizuka B
    J Obstet Gynaecol Res; 2009 Jun; 35(3):490-4. PubMed ID: 19527388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic factors for central recurrence in patients with locally advanced bulky cervical cancer.
    Lee WM; Park SI; Kim BJ; Kim MH; Choi SC; Lee ED; Ryu SY
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):219-23. PubMed ID: 22326616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.